Why is Paxman AB ?
- The company has been able to generate a Return on Equity (avg) of 5.08% signifying low profitability per unit of shareholders funds
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -26.27%, its profits have fallen by -70.6%
- Along with generating -26.27% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Paxman AB for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK 28.72 MM
Highest at 8.85%
Highest at SEK 67.13 MM
Highest at SEK 193.03 MM
Lowest at -51.89 %
Lowest at 88.55
Grown by 29.15% (YoY
Highest at SEK 11.72 MM
Lowest at SEK 10.38 MM
Lowest at 15.47 %
Lowest at SEK -5.53 MM
Lowest at SEK -5.51 MM
Lowest at SEK -0.29
Here's what is working for Paxman AB
Operating Cash Flows (SEK MM)
Net Sales (SEK MM)
Inventory Turnover Ratio
Cash and Cash Equivalents
Debt-Equity Ratio
Here's what is not working for Paxman AB
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Interest Paid (SEK MM)
Operating Profit to Interest
Interest Paid (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)
Raw Material Cost as a percentage of Sales






